Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

NCT00527735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Ipilimumab
DRUG: Placebo
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Bristol-Myers Squibb